148 related articles for article (PubMed ID: 28989094)
1. Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinoma.
Lim C; Bhangui P; Salloum C; Gómez-Gavara C; Lahat E; Luciani A; Compagnon P; Calderaro J; Feray C; Azoulay D
J Hepatol; 2017 Oct; ():. PubMed ID: 28989094
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A.
Wei M; Chen S; Li J; Li B; Shen J; Peng Z; Zhou Q; Zou Y; He X; Li S; Li D; Peng B; Lai J; Peng S; Qin B; Kuang M
Ann Surg Oncol; 2020 Oct; 27(10):3740-3753. PubMed ID: 32424586
[TBL] [Abstract][Full Text] [Related]
3. Impact of time-to-surgery on outcomes of patients undergoing curative-intent liver resection for BCLC-0, A and B hepatocellular carcinoma.
Tsilimigras DI; Hyer JM; Diaz A; Moris D; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
J Surg Oncol; 2021 Feb; 123(2):381-388. PubMed ID: 33174627
[TBL] [Abstract][Full Text] [Related]
4. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
[TBL] [Abstract][Full Text] [Related]
6. Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number.
Hu XS; Yang HY; Leng C; Zhang ZW
World J Gastroenterol; 2022 Nov; 28(44):6271-6281. PubMed ID: 36504552
[TBL] [Abstract][Full Text] [Related]
7. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
8. Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
Yang SY; Yan ML; Duan YF; Feng JK; Ye JZ; Xiang YJ; Liu ZH; Guo L; Xue J; Cheng SQ; Guo WX
Hepatol Int; 2022 Aug; 16(4):892-905. PubMed ID: 35704267
[TBL] [Abstract][Full Text] [Related]
9. Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma-a multicenter propensity score matching analysis.
Xu XF; Wu H; Li JD; Yao LQ; Huang B; Diao YK; Chen TH; Gu WM; Chen Z; Li J; Zhang YM; Wang H; Liang YJ; Zhou YH; Li C; Wang MD; Zhang CW; Pawlik TM; Lau WY; Shen F; Yang T
Hepatobiliary Surg Nutr; 2023 Jun; 12(3):314-327. PubMed ID: 37351131
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.
Koh YX; Tan HL; Lye WK; Kam JH; Chiow AKH; Tan SS; Choo SP; Chung AYF; Goh BKP
World J Hepatol; 2018 Jun; 10(6):433-447. PubMed ID: 29988922
[TBL] [Abstract][Full Text] [Related]
11. Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis.
Tong Y; Cai R; Li JX; Chang DH; Wang LZ; Cai WW; Xiao YD
Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1602-1614. PubMed ID: 36285593
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic versus open liver resection for resectable HCC with BCLC stage B: a propensity score-matched analysis.
Peng Y; Chen K; Li B; Xu H; Wei Y; Liu F
Updates Surg; 2022 Aug; 74(4):1291-1297. PubMed ID: 35739381
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular Carcinoma.
Zhu P; Liao W; Zhang WG; Chen L; Shu C; Zhang ZW; Huang ZY; Chen YF; Lau WY; Zhang BX; Chen XP
Ann Surg; 2023 Jan; 277(1):e103-e111. PubMed ID: 35081573
[TBL] [Abstract][Full Text] [Related]
14. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
[TBL] [Abstract][Full Text] [Related]
15. Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.
Lim C; Goumard C; Casellas-Robert M; Lopez-Ben S; Lladó L; Busquets J; Salloum C; Albiol-Quer MT; Castro-Gutiérrez E; Rosmorduc O; Feray C; Ramos E; Figueras J; Scatton O; Azoulay D
World J Surg; 2020 Jun; 44(6):1966-1974. PubMed ID: 32095855
[TBL] [Abstract][Full Text] [Related]
16. Does microvascular invasion in Barcelona Clinic Liver Cancer stage A multinodular hepatocellular carcinoma indicate early-stage behavior?
Wang H; Feng LH; Qian YW; Cao ZY; Wu MC; Cong WM
Ann Transl Med; 2019 Sep; 7(18):428. PubMed ID: 31700864
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages.
Guo H; Wu T; Lu Q; Li M; Guo JY; Shen Y; Wu Z; Nan KJ; Lv Y; Zhang XF
Cancer Manag Res; 2018; 10():361-369. PubMed ID: 29503583
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
[TBL] [Abstract][Full Text] [Related]
19. Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.
Tsilimigras DI; Bagante F; Moris D; Hyer JM; Sahara K; Paredes AZ; Mehta R; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Jul; 27(7):2321-2331. PubMed ID: 32285278
[TBL] [Abstract][Full Text] [Related]
20. Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
Han JE; Cho HJ; Cheong JY; Lim SG; Yang MJ; Noh CK; Lee GH; Kim SS
World J Gastroenterol; 2023 Dec; 29(47):6122-6137. PubMed ID: 38186683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
